JNJ

SEC source: 0000200406-25-000019 · wk-form4_1739400827.xml · derivative · entry 1

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,282

Underlying: Common Stock · 19,282 shares

Expires not disclosed

F1 · derivative.exercise_price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.

F1 · derivative.expiration_date: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.

F2 · balance_after: The total number of PSUs has been revised to reflect that certain PSUs, originally granted on February 14, 2022, were forfeited based on performance conditions set forth in the award agreement.

SEC source: 0000200406-25-000021 · wk-form4_1739401614.xml · derivative · entry 1

Swanson James D. · CIK 0001904785 · EVP, CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,118

Underlying: Common Stock · 3,118 shares

Expires not disclosed

F1 · derivative.exercise_price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.

F1 · derivative.expiration_date: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.

F2 · balance_after: The total number of PSUs has been revised to reflect that certain PSUs, originally granted on February 14, 2022, were forfeited based on performance conditions set forth in the award agreement.

SEC source: 0000200406-25-000023 · wk-form4_1739401822.xml · derivative · entry 1

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,806

Underlying: Common Stock · 2,806 shares

Expires not disclosed

F1 · derivative.exercise_price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.

F1 · derivative.expiration_date: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.

F2 · balance_after: The total number of PSUs has been revised to reflect that certain PSUs, originally granted on February 14, 2022, were forfeited based on performance conditions set forth in the award agreement.

SEC source: 0000200406-25-000025 · wk-form4_1739402273.xml · derivative · entry 1

Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,465

Underlying: Common Stock · 15,465 shares

Expires not disclosed

F1 · derivative.exercise_price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.

F1 · derivative.expiration_date: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.

F2 · balance_after: The total number of PSUs has been revised to reflect that certain PSUs, originally granted on February 14, 2022, were forfeited based on performance conditions set forth in the award agreement.

SEC source: 0000200406-25-000027 · wk-form4_1739402472.xml · derivative · entry 1

Mulholland Kristen · CIK 0002037288 · EVP, Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,601

Underlying: Common Stock · 1,601 shares

Expires not disclosed

F1 · derivative.exercise_price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.

F1 · derivative.expiration_date: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.

F2 · balance_after: The total number of PSUs has been revised to reflect that certain PSUs, originally granted on February 14, 2022, were forfeited based on performance conditions set forth in the award agreement.

SEC source: 0000200406-25-000029 · wk-form4_1739403114.xml · derivative · entry 1

Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,837

Underlying: Common Stock · 5,837 shares

Expires not disclosed

F1 · derivative.exercise_price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.

F1 · derivative.expiration_date: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.

F2 · balance_after: The total number of PSUs has been revised to reflect that certain PSUs, originally granted on February 14, 2022, were forfeited based on performance conditions set forth in the award agreement.

SEC source: 0000200406-25-000031 · wk-form4_1739403336.xml · derivative · entry 1

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,316

Underlying: Common Stock · 15,316 shares

Expires not disclosed

F1 · derivative.exercise_price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.

F1 · derivative.expiration_date: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.

F2 · balance_after: The total number of PSUs has been revised to reflect that certain PSUs, originally granted on February 14, 2022, were forfeited based on performance conditions set forth in the award agreement.

SEC source: 0000200406-25-000033 · wk-form4_1739403421.xml · derivative · entry 1

Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,352

Underlying: Common Stock · 1,352 shares

Expires not disclosed

F1 · derivative.exercise_price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.

F1 · derivative.expiration_date: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.

F2 · balance_after: The total number of PSUs has been revised to reflect that certain PSUs, originally granted on February 14, 2022, were forfeited based on performance conditions set forth in the award agreement.

SEC source: 0000200406-25-000035 · wk-form4_1739403530.xml · derivative · entry 1

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,351

Underlying: Common Stock · 1,351 shares

Expires not disclosed

F1 · derivative.exercise_price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.

F1 · derivative.expiration_date: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.

F2 · balance_after: The total number of PSUs has been revised to reflect that certain PSUs, originally granted on February 14, 2022, were forfeited based on performance conditions set forth in the award agreement.

SEC source: 0000200406-25-000012 · wk-form4_1739320809.xml · derivative · entry 5

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,015 shares

Expires 2025-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.expiration_date: Reflects the exercise of options immediately prior to their expiration.

SEC source: 0000200406-25-000012 · wk-form4_1739320809.xml · nonDerivative · entry 2

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F2 · price: This transaction was executed in multiple trades at prices ranging from $153.86 to $153.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000200406-25-000012 · wk-form4_1739320809.xml · nonDerivative · entry 1

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,015

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reflects the exercise of options immediately prior to their expiration.

SEC source: 0000200406-25-000013 · wk-form4_1739320870.xml · derivative · entry 3

Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 58,504 shares

Expires 2025-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.expiration_date: Reflects the auto-exercise of options immediately prior to their expiration.

SEC source: 0000200406-25-000013 · wk-form4_1739320870.xml · nonDerivative · entry 2

Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,919.001

F2 · shares: Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on this Form 4.

SEC source: 0000200406-25-000013 · wk-form4_1739320870.xml · nonDerivative · entry 1

Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 213,355.001

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reflects the auto-exercise of options immediately prior to their expiration.

SEC source: 0000200406-25-000014 · wk-form4_1739320931.xml · derivative · entry 5

Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 32,762 shares

Expires 2025-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.expiration_date: Reflects the auto-exercise of options immediately prior to their expiration.

SEC source: 0000200406-25-000014 · wk-form4_1739320931.xml · nonDerivative · entry 2

Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,951.8735

F2 · shares: Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on this Form 4.

SEC source: 0000200406-25-000014 · wk-form4_1739320931.xml · nonDerivative · entry 1

Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,027.8735

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reflects the auto-exercise of options immediately prior to their expiration.

SEC source: 0000200406-25-000015 · wk-form4_1739320983.xml · derivative · entry 4

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 126,369 shares

Expires 2025-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.expiration_date: Reflects the auto-exercise of options immediately prior to their expiration.

SEC source: 0000200406-25-000015 · wk-form4_1739320983.xml · nonDerivative · entry 2

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 389,028

F2 · shares: Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on this Form 4.

SEC source: 0000200406-25-000015 · wk-form4_1739320983.xml · nonDerivative · entry 1

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 489,671

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reflects the auto-exercise of options immediately prior to their expiration.

SEC source: 0000200406-24-000106 · wk-form4_1734042449.xml · nonDerivative · entry 1

WEINBERGER MARK A · CIK 0001785997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000

SEC source: 0000200406-24-000102 · wk-form4_1734041373.xml · derivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,380.2237

Underlying: Common Stock · 334.523 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0000200406-24-000104 · wk-form4_1734041779.xml · derivative · entry 1

Woods Eugene A. · CIK 0001762647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,804.5872

Underlying: Common Stock · 208.793 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0000200406-24-000090 · wk-form4_1729549096.xml · nonDerivative · entry 3

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Indirect · By SLAT

Disclosed balance after: 68,835

F1 · ownership.nature: Held in a spousal lifetime access trust, of which the reporting person's spouse is the trustee and beneficiary.

SEC source: 0000200406-24-000090 · wk-form4_1729549096.xml · nonDerivative · entry 2

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

SEC source: 0001225208-24-008646 · doc4.xml · derivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,954.9397

Underlying: Common Stock · 302.547 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-24-008647 · doc4.xml · derivative · entry 1

Woods Eugene A. · CIK 0001762647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,574.4652

Underlying: Common Stock · 188.321 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-24-008326 · doc4.xml · derivative · entry 5

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,635 shares

Expires 2025-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-24-008326 · doc4.xml · nonDerivative · entry 2

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,973

SEC source: 0001225208-24-008326 · doc4.xml · nonDerivative · entry 1

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,608

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-24-007379 · doc4.xml · derivative · entry 3

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,809 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on July 1, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.

F1 · derivative.exercise_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on July 1, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.

F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on July 1, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.

SEC source: 0001225208-24-007379 · doc4.xml · nonDerivative · entry 2

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,834

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

SEC source: 0001225208-24-007379 · doc4.xml · nonDerivative · entry 1

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,852

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on July 1, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.

SEC source: 0001225208-24-006707 · doc4.xml · derivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,573.3827

Underlying: Common Stock · 314.6179 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-24-006708 · doc4.xml · derivative · entry 1

Woods Eugene A. · CIK 0001762647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,368.4462

Underlying: Common Stock · 211.3629 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0000200406-24-000090 · wk-form4_1729549096.xml · nonDerivative · entry 1

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,835

SEC source: 0001225208-24-005567 · doc4.xml · derivative · entry 3

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,510

Underlying: Common Stock · 22,255 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Share Units awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

F1 · derivative.exercise_date: The Restricted Share Units awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

F1 · derivative.expiration_date: The Restricted Share Units awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

SEC source: 0001225208-24-005567 · doc4.xml · nonDerivative · entry 2

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,577

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

SEC source: 0001225208-24-005567 · doc4.xml · nonDerivative · entry 1

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,561

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Share Units awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

SEC source: 0000200406-24-000098 · wk-form4a_1730411857.xml · derivative · entry 3

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,510

Underlying: Common Stock · 25,255 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Share Units awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

F1 · derivative.exercise_date: The Restricted Share Units awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

F1 · derivative.expiration_date: The Restricted Share Units awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

SEC source: 0000200406-24-000098 · wk-form4a_1730411857.xml · nonDerivative · entry 2

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,577

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

SEC source: 0000200406-24-000098 · wk-form4a_1730411857.xml · nonDerivative · entry 1

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,561

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Share Units awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

SEC source: 0000200406-25-000091 · wk-form5_1740787536.xml · nonDerivative · entry 2

Woods Eugene A. · CIK 0001762647 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 250

SEC source: 0001225208-24-005328 · doc4.xml · derivative · entry 1

Doudna Jennifer A · CIK 0001739090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,081.638

Underlying: Common Stock · 1,385.697 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-24-005329 · doc4.xml · derivative · entry 1

Johnson Paula A · CIK 0001341161 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,858.548

Underlying: Common Stock · 1,385.697 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-24-005330 · doc4.xml · derivative · entry 1

Joly Hubert · CIK 0001467638 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,464.145

Underlying: Common Stock · 1,385.697 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-24-005331 · doc4.xml · derivative · entry 1

McClellan Mark B. · CIK 0001567006 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,867.715

Underlying: Common Stock · 1,385.697 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-24-005332 · doc4.xml · derivative · entry 1

MULCAHY ANNE M · CIK 0001201725 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,470.618

Underlying: Common Stock · 1,385.697 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-24-005333 · doc4.xml · derivative · entry 1

WEINBERGER MARK A · CIK 0001785997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,129.352

Underlying: Common Stock · 1,385.697 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.